- Report
- August 2024
- 243 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- April 2025
- 233 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- December 2023
- 164 Pages
Global
From €2139EUR$2,350USD£1,834GBP
- Report
- May 2023
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- August 2022
- 115 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- January 2023
- 170 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- October 2023
- 172 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2023
- 118 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2023
- 146 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- March 2023
- 428 Pages
Global
From €3358EUR$3,690USD£2,879GBP
The Reusable Injection Pen market is a subset of the larger Needles and Syringes market. Reusable Injection Pens are medical devices used to inject medication into the body. They are designed to be used multiple times, and are typically used to inject insulin or other medications. Reusable Injection Pens are typically made of plastic and contain a needle, a plunger, and a cartridge. The needle is used to penetrate the skin, the plunger is used to inject the medication, and the cartridge is used to store the medication.
Reusable Injection Pens are becoming increasingly popular due to their convenience and cost-effectiveness. They are easy to use and require minimal maintenance. Additionally, they are more environmentally friendly than disposable syringes, as they can be reused multiple times.
Some companies in the Reusable Injection Pen market include Becton Dickinson, Novo Nordisk, Ypsomed, Owen Mumford, and Haselmeier. Show Less Read more